Circulating leptin and body composition in chronic obstructive pulmonary disease

International Journal of Clinical Practice

Volumn 59, Issue 10, 2005, Pages 1167-1170

  Karakas, S ^a   Karadag, Fisun ^a   Karul, A B ^a   Gurgey, O ^a   Gurel, S ^a   Guney, E ^a   Cildag, O ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Body composition; Body mass index; Chronic obstructive pulmonary disease; Leptin

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEPTIN;

AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENERGY BALANCE; ENERGY EXPENDITURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; NUTRITIONAL DISORDER; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; SKINFOLD THICKNESS; SPIROMETRY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ANTHROPOMETRY; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; HUMANS; LEPTIN; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 33644837990     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2005.00567.x     Document Type: Article

References (25)

1. Mador MJ, Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2001; 2: 216-24.
2. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-61.
3. Raida I, Khan H, Fleg JI, Wise RA. Body mass index and risk of COPD. Chest 2002; 121: 270-6.
4. Harik-Khan RI, Wise RA, Fleg JL. The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol 2001; 54: 399-406.
5. Schols AMWJ, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-7.
6. Auwerx J, Staels B. Leptin. Lancet 1998; 351: 737-42.
7. Flier JS. Leptin expression and action: New experimental paradigms. Proc Natl Acad Sci USA 1997; 94: 4242-5.
8. Smith FJ, Campfield LA, Moschera JA, Bailon PS, Bum P. Brain administration of OB protein inhibits neuropeptide-Y induced feeding of ob/ob mice. Regulatory Peptides 1998; 75: 433-9.
9. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118: 580-6.
10. O'donnell CP, Schaub CD, Haines AS et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 1999; 159: 1477-84.
11. Creutzberg EC, Wouters EFM, Vonderhoven-Augustin IML, Dentener MA, Schols AMWJ. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1239-45.
12. Schols AMWJ, Creutzberg EC, Buurman WA, Campfield LA, Saris WHM, Wouters EFM. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1220-6.
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 77-120.
14. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 1995; 152: 1107-36.
15. ERS Consensus Statement. Optimal assessment and management of chronic obstructive pulmonary disease. Eur Respir J 1995; 8: 1398-420.
16. Heyward VH. Practical body composition assessment for children, adults, and older adults. Int J Sport Nutr 1998; 8: 285-307.
17. Frieman J, Halaas JL. Leptin and regulation of body weight in mammals. Nature 1998; 395: 763-9.
18. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: Results from the Copenhagen City Heart Study. Eur Respir J 2002; 20: 539-44.
19. Takabatake N, Nakamura H, Abe S et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1215-9.
20. Karadag F, Karul AB, Cildag O, Altun C, Gurgey O. Determinants of BMI in patients with COPD. Respirology 2004; 9: 70-5.
21. Thurlbeck WM. Diaphragm and body weight in emphysema. Thorax 1978; 54: 396-402.
22. Schols AMWJ, Soeters JPB, Mostert R, Saris WHM, Wouters EFM. Energy balance in COPD. Am Rev Respir Dis 1991; 143: 1248-52.
23. Maffei M, Halaas J, Ravussin E et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-61.
24. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
25. Yuan Y, Wang Z, Liu C. Preliminary investigation of effect of serum leptin on nutritional state of COPD patients. Zhonghua Jie He He Hu Xi Za Zhi 2000; 23: 292-5.